ORIGINAL RESEARCH
Accepted on 04 Apr 2025
Adverse reactions of four multi-targeted tyrosine kinase inhibitors: a descriptive analysis of the WHO-VigiAccess database
doi 10.3389/fphar.2025.1585862
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Genomic Discoveries and Pharmaceutical Development in Urologic Tumors - Volume II
Genomic Discoveries and Pharmaceutical Development in Urologic Tumors - Volume II
104
Total downloads
1,223
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Accepted on 04 Apr 2025
Multiscale Screening and Identifying Specific Targets for Artesunate in Suppressing Bladder Cancer
doi 10.3389/fphar.2025.1584502
ORIGINAL RESEARCH
Published on 01 Apr 2025
Exploring the impact of cuproptosis on prostate cancer prognosis via RNA methylation regulation based on single cell and bulk RNA sequencing data
doi 10.3389/fphar.2025.1573611
- 151 views
ORIGINAL RESEARCH
Published on 28 Mar 2025
MiR-146b overexpression promotes bladder cancer cell growth via the SMAD4/C-MYC/Cyclin D1 axis
doi 10.3389/fonc.2025.1565638
- 217 views
ORIGINAL RESEARCH
Published on 27 Mar 2025
The characteristics of adverse reactions of three anti-prostate cancer drugs based on Vigiaccess database and bibliometric analysis
doi 10.3389/fphar.2025.1570661
- 201 views
Published in
Frontiers in Pharmacology
Pharmacology of Anti-Cancer Drugs
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: